Abbott Labs wrongly pushed Depakote for dementia care, will pay $1.5 billion
By
McKnight's Staff
May 07, 2012
Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration.